Wuhan Dazhong Dental Medical Co., Ltd. (HKG:2651)

Market Cap	741.67M
Revenue (ttm)	433.21M
Net Income (ttm)	38.88M
Shares Out	49.38M
EPS (ttm)	1.00
PE Ratio	15.09
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	119,800
Average Volume	407,406
Open	14.26
Previous Close	14.48
Day's Range	14.24 - 15.60
52-Week Range	14.24 - 27.50
Beta	n/a
RSI	20.30
Earnings Date	n/a

About Theseus Pharmaceuticals

Wuhan Dazhong Dental Medical Co., Ltd. operates as a dental services provider in Central China with a focus on Hubei and Hunan provinces. The company operates through three segments, General Dentistry Services, which offers regular oral health management and early intervention of dental diseases, including prosthodontics, oral medicine, oral surgery, and pedodontics; Implantology services, that offers teeth replacement solutions to replace the natural teeth with implants; and Orthodontics services, that engages in aesthetic alignment of teeth t...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2007
• Employees: 1,164
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2651

Financial Performance

In 2024, HKG:2651's revenue was 407.08 million, a decrease of -7.87% compared to the previous year's 441.84 million. Earnings were 36.53 million, a decrease of -16.83%.